College of Veterinary Medicine and Bio-Safety Research Institute, Chonbuk National University, Jeonju 561-756, South Korea.
Vet Microbiol. 2010 Jul 14;143(2-4):270-6. doi: 10.1016/j.vetmic.2009.11.034. Epub 2009 Dec 3.
This study was carried out to examine a novel Salmonella Typhimurium (S. Typhimurium) vaccine for protection of suckling piglets against salmonellosis by immunization of pregnant sows using various administration routes. The vaccine strain was constructed by deletion of cpxR and lon from a wild type S. Typhimurium and the S. Typhimurium Delta cpxR Delta lon Delta asd secreting the B subunit of the Escherichia coli heat-labile enterotoxin were used as a live form of mucosal adjuvant for this study. Pregnant sows were divided into 4 groups of 3 sows a piece. Sows were primed at 8 weeks of pregnancy and were boosted 11 weeks of pregnancy. Group A sows were primed intramuscularly with the formalin-inactivated vaccine and boosted orally with the live vaccine and mucosal adjuvant, group B sows were orally primed with the live vaccine and mucosal adjuvant and boosted orally with live vaccine, group C sows were orally primed with live vaccine and mucosal adjuvant and intramuscularly boosted, and group D sows were primed and boosted with phosphate-buffered saline as controls. Piglets were orally challenged with a virulent S. Typhimurium strain at day 6 after birth. Sows from group A and B had significantly increased IgG levels compared to control group sows (P<0.05), and group C sows had lower IgG levels compared to group A and B sows. Mucosal sIgA and IgG levels in group A and B sow colostrums were significantly increased as compared to those of group D sows (P<0.05). Serum IgG and IgA levels in group A and B piglets were also significantly increased as compared to those of group D piglets (P<0.001). These data suggested that systemic and mucosal immune responses were highly induced by the vaccine candidate, especially when this was administered by both routes of intramuscular-prime and oral booster, and oral prime and booster. Furthermore, clinical signs such as diarrhea and weight loss were not observed after virulent Salmonella strain challenge in group A and B suckling piglets, however, group C (41.7%) and group D (83.3%) piglets suffered from diarrhea. This data suggested that sow immunized by intramuscular-prime and oral booster and oral prime and oral booster with this vaccine candidate effectively protected piglets from salmonellosis.
本研究旨在通过对妊娠母猪进行免疫接种,探讨一种新型的鼠伤寒沙门氏菌(S. Typhimurium)疫苗,以保护哺乳仔猪免受沙门氏菌病的侵害。疫苗株是通过缺失野生型 S. Typhimurium 的 cpxR 和 lon 构建的,而 S. Typhimurium Delta cpxR Delta lon Delta 则作为黏膜佐剂的活形式分泌大肠杆菌不耐热肠毒素 B 亚单位。将妊娠母猪分为 4 组,每组 3 头。母猪在妊娠 8 周时进行初次免疫,妊娠 11 周时进行加强免疫。A 组母猪肌肉注射福尔马林灭活疫苗,口服接种活疫苗和黏膜佐剂进行加强免疫;B 组母猪口服接种活疫苗和黏膜佐剂进行初次免疫,口服接种活疫苗进行加强免疫;C 组母猪口服接种活疫苗和黏膜佐剂,肌肉注射加强免疫;D 组母猪用磷酸盐缓冲液作为对照进行初次和加强免疫。仔猪在出生后第 6 天经口攻毒强毒鼠伤寒沙门氏菌。与对照组母猪相比,A 组和 B 组母猪的 IgG 水平显著升高(P<0.05),而 C 组母猪的 IgG 水平低于 A 组和 B 组。与 D 组母猪相比,A 组和 B 组母猪初乳中的黏膜 sIgA 和 IgG 水平显著升高(P<0.05)。A 组和 B 组仔猪的血清 IgG 和 IgA 水平也显著高于 D 组仔猪(P<0.001)。这些数据表明,候选疫苗能高度诱导全身和黏膜免疫应答,特别是当通过肌肉初免和口服加强免疫以及口服初免和加强免疫两种途径进行免疫时。此外,在 A 组和 B 组哺乳仔猪经强毒沙门氏菌攻毒后,未观察到腹泻和体重减轻等临床症状,但 C 组(41.7%)和 D 组(83.3%)仔猪出现腹泻。这些数据表明,用该候选疫苗对母猪进行肌肉初免和口服加强免疫以及口服初免和口服加强免疫可有效保护仔猪免受沙门氏菌病的侵害。